» Articles » PMID: 7489472

Paediatric Ventilatory Effects of Morphine and Buprenorphine Revisited

Overview
Date 1995 Jan 1
PMID 7489472
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The study describes long term ventilatory effects of 50 or 100 micrograms.kg-1 of morphine or 1.5 or 3.0 micrograms.kg-1 of buprenorphine when given in repeated intravenous (i.v.) doses, in a double blind fashion, to achieve equal levels of analgesia after thoracotomy. The patients were 56 children, six months to six years of age. Ventilatory rate (VR) was measured over the 24 h study period, and arterial carbon dioxide tension (PaCO2) was measured on arrival in the Paediatric Intensive Care Unit (PICU) and at 1, 6, 12 and 18 h. In the buprenorphine groups VRs progressively decreased during the first 2 h and remained significantly lower (P < 0.05) than in the morphine groups for 7 h. For the rest of the study period there were no differences. The PaCO2 values did not differ significantly at any point. For safety, prolonged observation of children is needed after intravenous administration of buprenorphine to ensure the ventilatory rate has stabilized.

Citing Articles

An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Modulator Buprenorphine.

Pande L, Arnet R, Piper B Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895868 PMC: 10610465. DOI: 10.3390/ph16101397.


Assessment of Intraoperative Hemodynamics and Recovery Characteristics in Pediatric Patients Receiving Buprenorphine and Propofol Anesthesia for Cleft Palate Surgery: A Prospective Observational Study.

Lakra P, Thaware P, Bharati Anesth Essays Res. 2022; 16(2):255-262.

PMID: 36447914 PMC: 9701334. DOI: 10.4103/aer.aer_95_22.


Buprenorphine versus Morphine in Paediatric Acute Pain: A Systematic Review and Meta-Analysis.

Murray N, Malla U, Vlok R, Scott A, Chua O, Melhuish T Crit Care Res Pract. 2018; 2018:3792043.

PMID: 30159170 PMC: 6109565. DOI: 10.1155/2018/3792043.


Management of opioid analgesic overdose.

Boyer E N Engl J Med. 2012; 367(2):146-55.

PMID: 22784117 PMC: 3739053. DOI: 10.1056/NEJMra1202561.


Transdermal buprenorphine in the management of persistent pain - safety aspects.

Likar R Ther Clin Risk Manag. 2008; 2(1):115-25.

PMID: 18360586 PMC: 1661652.